Physician profile
Brandon Brooks
NPI 1962455204
$4,788.19
in general payments reported to CMS, 2019-2025
19 companies · $1,657 in 2025
The $1,657 reported for 2025 was more than what 78% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $36.50 · 2021: $137 · 2022: $1,432 · 2023: $677 · 2024: $732 · 2025: $1,657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,175 · Travel and Lodging: $890.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,175.45 |
| Travel and Lodging | $889.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $1,404.32 | 2023-2025 | Evoke, Evoke Scs |
| Nevro Corp. | $633.42 | 2019-2024 | Senza |
| Medtronic, INC. | $567.63 | 2022 | |
| Abbott Laboratories | $550.17 | 2021-2025 | Proclaim |
| Spr Therapeutics, INC | $465.63 | 2022-2025 | Sprint Pns System |
| Boston Scientific Corporation | $287.90 | 2022-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Globus Medical, INC. | $194.67 | 2025 | Senza |
| Novo Nordisk INC | $144.43 | 2023-2024 | Wegovy |
| Abbvie INC. | $139.11 | 2022-2024 | Qulipta, Botox, Ubrelvy |
| Lilly USA, LLC | $98.98 | 2023-2025 | Emgality, Zepbound, Jardiance |
| Averitas Pharma INC. | $80.51 | 2023-2025 | Qutenza |
| Depuy Synthes Sales INC. | $39.24 | 2022 | |
| Collegium Pharmaceutical, INC. | $34.16 | 2022-2023 | Belbuca |
| Stryker Corporation | $31.26 | 2025 | Mild Device Kit |
| Amgen INC. | $26.25 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $25.88 | 2022 | |
| Relievant Medsystems, INC. | $23.02 | 2023 | Intracept |
| Pacira Pharmaceuticals Incorporated | $22.03 | 2024 | Iovera |
| Spinal Simplicity, LLC | $19.58 | 2025 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.